Navigation Links
The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
Date:9/19/2007

PITTSBURGH, Sept. 19 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that the PLSG has invested $150,000 in Coventina Healthcare Enterprises, Inc., a medical device company that provides therapeutic warming (using Radio Frequency) and multi-modal treatment systems for research, rehabilitation, and management of pain related to injury, aging and disease.

Coventina recently acquired the assets of SeliCor, Inc., a Texas company, and has established operations in southwestern Pennsylvania.

The SeliTherm(TM) System, Coventina's FDA cleared therapeutic warming device, consists of a Radio Frequency (RF) generator and a family of form-fitting garments containing helically coiled wires which deliver gentle, deep, therapeutic heating along the length of the body part during treatment. This highly efficient, longitudinal field surrounds and gently "bathes" the treatment area in RF energy. This approach virtually eliminates the risk of injury to the patient, removes the need for attended delivery, and allows the person to experience effective and comfortable therapeutic warming.

Therapeutic warming (raising the temperature of the tissues 1.0 to 1.6 inches below the surface of the skin to a temperature between 104 degrees Fahrenheit and 113 degrees Fahrenheit) causes certain physiological changes to take place in the treated tissues. These physiological changes result in pain relief, decreased joint stiffness, increased range of motion, relief from muscle spasms and joint contractures, and accelerated healing of soft tissue injuries.

"We welcome Coventina to our regional life sciences community," said John W. Manzetti, PLSG's President and CEO. "Our region is well poised to become a global life sciences leader and it is the perfect place for a young life sciences company to form and prosper." Mr. Manzetti continued, "The
'/>"/>

SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Milwaukee angel network invests in St. Louis company
2. Froedtert invests $1.5M in local medical imaging startup
3. GE Healthcare invests $37.5 million in Chinese bio-sciences manufacturing facility
4. Wisconsin Insurance Company Invests in DotCom Company
5. Web-based reporting credited with states top healthcare ranking
6. Visions: Preizler offers insurers perspective on healthcare IT
7. Federal bill would set healthcare IT standards
8. IRS ruling could speed healthcare technology adoption
9. Bill would provide federal aid for healthcare IT
10. DHC 2007: Hayden says technology creates magic moment for healthcare delivery
11. Digital Healthcare Conference 2007: Mounting obstacles for health IT

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/ ... leading provider of tools and services for drug d...ced Living Image 4.0 software for IVIS® in vi...he more than 800 Caliper IVIS systems currently in...0 features advanced spectral unmixing tools to enh...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Carbondioxi... http://www.reportlinker.com/p0164368/Carbondioxi... ,, Incubators are the most critical equipment ...and other applications for providing a controlled ...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - On...y") (TSX:ONC; NASDAQ: ONCY ) announced today that ...ffering, the underwriters have exercised in full t...onal 637,500 units. Each unit is comprised of one ...rrant, and was sold at a price of US$3.00 per unit...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte ...l oral JAK2 inhibitor, SB1518, at The American Soc...ion in New Orleans. ,, Data will be presented o...ation trial of SB1518 detailing its safety, tolera... profile in dose levels ranging from 100 to 600 mg...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...al School Researchers Used Thermo Scientific Dharm... for Reproduction of the Virus that ...31 Thermo Fisher,Scientific Inc., the world leade...-interference (RNAi) technology has enabled a grou...on, which identified human proteins,required for g...
... Manufacture ARIUS, Product Candidate Trop-2 Signa... PRINCETON, N.J., Jan. 31 Laureate Pharma, Inc., ...protein production company, today,announced that i...greement,with ARIUS Research, Inc., a biotechnolog...e next wave of antibody therapeutics to treat canc...
...d Balance Sheet and Advancing Products in 2008 - .... Eastern Time -, BRANFORD, Conn., Jan. 31 CuraG... consolidated financial results for the,fourth qua...raGen reported a loss from operations for the four...share, which included restructuring charges,totali...
Other Biology Technology:Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 2Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 3Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 4Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 5Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 2Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 3CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 2CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 3CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 4CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 5CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 6CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 7
(Date:12/3/2009)...n Antarctic snowmelt that occurred during the 2008...rong positive phases for two main climate drivers,...thern Hemisphere Annular Mode), according to Dr. M...pheric Sciences at The City College of New York. ...l faculty at the CUNY Graduate Center, added that ...
(Date:12/2/2009)... who smoke their first cigarette within minutes af... a by-product of nicotine when processed by the bo...e number of cigarettes smoked. , "Since cotin...er, our results suggest that smokers who smoke imm...r lung cancer," said researcher Joshua E. Muscat, ...
(Date:12/2/2009)..., peanut butter, and other foods have done more th...afety. They also are quietly fueling a boom in the...ew food safety regulations. That,s the topic of th...emical & Engineering News , (C&EN) ACS, weekly new...ey and Senior Correspondent Marc Reisch point out ...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2Is Smoking Tougher on Women 3F 60033 1Is Smoking Tougher on Women 3F 60033 2Is Smoking Tougher on Women 3F 60033 3New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction 5670 1New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction 5670 2Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 1Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 2
...searchers at Harvard Medical School and Massachuse...at the 13th European Cancer Conference (ECCO) have...ery is possible using nanoparticle-apatamer conjug...mers) are short DNA or RNA fragments that can bind...nity; analogous to monoclonal antibodies. In the f...
... to suppress HIV replication and has dramatically ...d patients. But the existence of viral reservoirs...eated patients. In a new study appearing on Novemb...-Wook Chun and colleagues from the NIH offer new i...ividuals receiving antiviral therapy. , The autho...
...ocally the coolest - pieces of real estate on the ...g a state-of-the-art superconducting magnet for us... DNA, RNA, enzymes and other proteins. , The inst...r magnet was recently completed in a specially bui...n and a half tons, the magnetic resonance (MR) spe...
Other Biology News:Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 3Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 4Superconducting magnet attracts molecular research 2
Mouse Anti-Human Flavocytochrome b Monoclonal Antibody, FITC Conjugated, Clone 7D5 from MBL International
Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
Rabbit Anti-Human Reptin / TIP49B / RUVB2 Polyclonal Antibody, Unconjugated from Abcam
Anti-Human L-Ficolin Monoclonal Antibody, Unconjugated, Clone GN4 from Cell Sciences
Biology Products: